Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 3 years ago

Possible Interaction: Eicosapentaenoic Acid and Palmitoleic Acid

Research Papers that Mention the Interaction

EPA also altered the composition of fatty acids by lowering the MUFAs C16:1 and C18:1 and increasing n-3 PUFAs, including EPA and docosahexaenoic acid (DHA).
Prostaglandins, leukotrienes, and essential fatty acids  •  2009  |  View Paper
Infusion of C16:1 resulted in linear increases in tissue concentrations of palmitoleic, cis-11 vaccenic, eicosapentaenoic , and docosapentaenoic acids in a dose-dependent manner.
Diabetes, metabolic syndrome and obesity : targets and therapy  •  2014  |  View Paper